Max Chat
Hua Medicine (Shanghai) Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 37.2 | -100% | -14.04 | -100% |
| P/S |
|
5.33 | 4.03 | 32.33% |
|
|
| P/BV |
|
-10.07 | 1.93 | -620.75% |
|
|
| P/FCF |
|
-4.53 | -10.12 | -55.25% |
|
|
| Ev/Ebitda |
|
-8.84 | 2.91 | -404% |
|
|
| Ev/S |
|
5.82 | 7.34 | -20.64% |
|
|
| Ev/FCF |
|
-3.53 | -11 | -67.89% |
|
|
| E/P |
|
-0.131 | 0.0327 | -500.03% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-70.42 | 1.46 | -4924.25% | -512.69 | -86.26% |
| ROE |
|
1457.93 | 3.98 | 36571.2% |
|
|
| ROA |
|
-15.38 | 2.89 | -632.65% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
-97.75 | 10.86 | -999.99% |
|
|
| ROCE |
|
0 | 0.1527 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-1.32 | 0.3827 | -443.69% | -0.5622 | +133.94% |
| Nеt Debt/Ebitda |
|
5.01 | -0.2202 | -2375.49% |
|
|
| Debt/Ratio |
|
0.1552 | 0.132 | 17.55% |
|
|
| Debt/Equity |
|
-12.27 | 0.6875 | -1885.3% |
|
|
| Debt/Net Income |
|
-0.9475 | 2.61 | -136.33% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 4.32 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1.23 | -100% | ||
| DSI |
|
0 | 0.5482 | -100% |
|
|
| Average dividend growth |
|
0 | -2.77 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 4.29 | -100% |
|
|
| Average percentage for payments |
|
0 | 34.1 | -100% |
|
|
| Difference from average difference in sector |
|
-4.32 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
1354.01 | -94.75 | -1529.03% | ||
| Growth impulse Ebitda in 5 years |
|
-57.74 | -45.56 | 26.73% | ||
| Growth impulse Net Income in 5 years |
|
-36.37 | -111.86 | -67.49% | ||
| Growth impulse FCF in 5 years |
|
1917.73 | -138.06 | -1489.06% | ||
| Growth impulse EPS in 5 years |
|
518.83 | -139.77 | -471.2% |
IP Score
3.93/10
